We are pleased to announce that ReinVAD will join the Hybrid Heart consortium! ReinVAD will focus on the development of the wireless transcutaneous energy and data transfer system that will be used to power the Hybrid Heart.

About ReinVAD: ReinVAD GmbH is a spin-off company from the RWTH Aachen founded in 2012 and located in the south of Aachen. The company’s goal is to develop a new Left Ventricle Assist Device (LVAD) that can save the life of patients with severe heart failure reviving them with a high quality of life.